Product Dossier
ZATAMIL
Product Dossier for ZATAMIL (mometasone furoate, Ego Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Ego Pharmaceuticals
- Active ingredient: mometasone furoate
- Therapeutic area: Dermatology
- Related brand: RYALTRIS
- Related brand: Enerzair Breezhaler
- Related brand: Atectura Breezhaler
- Same area: DERMATANE
- Same area: NEOTIGASON
I appreciate your detailed instructions, but
I must note a significant issue with the source documents provided.
The document index 1 contains comprehensive product information for **NASONEX® Aqueous Nasal Spray** (a nasal corticosteroid), while document index 2 lists ARTG registrations for **ZATAMIL** (topical dermatological formulations: ointment, hydrogel, and lotion).
These are two entirely different medicines with different active ingredients (both are mometasone furoate but in different formulations and strengths), different indications, different routes of administration, and different sponsors (Organon Pharma vs. Ego Pharmaceuticals).
**The source documents do not contain product information for ZATAMIL.** Document 2 only provides bare ARTG registration metadata (registration numbers, strengths, formulation types, and first-listed dates) with no clinical, safety, dosing, or regulatory detail.
To write an accurate Brand Dossier for ZATAMIL following your specifications, I would need: — Product Information document(s) for ZATAMIL (not NASONEX) — Details on indications, dosing, safety warnings, contraindications, and regulatory history specific to ZATAMIL
**I cannot ethically provide a dossier by citing the NASONEX document for ZATAMIL, as this would misrepresent the information and potentially mislead readers about a registered Australian medicine.**
Please provide the correct source documents for ZATAMIL, and I will produce the Brand Dossier as specified.